NCT06758596View on ClinicalTrials.gov

Research Investigating Drug Effects-2 (RiDE-2)

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

July 15, 2026

Primary Completion Date

March 31, 2031

Study Completion Date

June 30, 2031

Conditions
Cannabis UseSubstance Use Disorder (SUD)Healthy
Interventions
DRUG

Placebo Oral Capsule

A capsule that contains only dextrose filler administered during the first or second laboratory visit.

DRUG

THC

A capsule that contains 7.5 mg of THC as well as dextrose filler administered during the first or second laboratory visit.

Trial Locations (1)

60612

University of Illinois at Chicago, Chicago

All Listed Sponsors
lead

University of Illinois at Chicago

OTHER

NCT06758596 - Research Investigating Drug Effects-2 (RiDE-2) | Biotech Hunter | Biotech Hunter